Company Quick10K Filing
Aceto
Closing Price ($) Shares Out (MM) Market Cap ($MM)
$3.62 31 $112
10-Q 2018-12-31 Quarter: 2018-12-31
10-Q 2018-09-30 Quarter: 2018-09-30
10-K 2018-06-30 Annual: 2018-06-30
10-Q 2018-03-31 Quarter: 2018-03-31
10-Q 2017-12-31 Quarter: 2017-12-31
10-Q 2017-09-30 Quarter: 2017-09-30
10-K 2017-06-30 Annual: 2017-06-30
10-Q 2017-03-31 Quarter: 2017-03-31
10-Q 2016-12-31 Quarter: 2016-12-31
10-Q 2016-09-30 Quarter: 2016-09-30
10-K 2016-06-30 Annual: 2016-06-30
10-Q 2016-03-31 Quarter: 2016-03-31
10-Q 2015-12-31 Quarter: 2015-12-31
10-Q 2015-09-30 Quarter: 2015-09-30
10-K 2015-06-30 Annual: 2015-06-30
10-Q 2015-03-31 Quarter: 2015-03-31
10-Q 2014-12-31 Quarter: 2014-12-31
10-Q 2014-09-30 Quarter: 2014-09-30
10-K 2014-06-30 Annual: 2014-06-30
10-Q 2014-03-31 Quarter: 2014-03-31
10-Q 2013-12-31 Quarter: 2013-12-31
8-K 2019-09-30 Bankruptcy, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2019-09-18 Bankruptcy, Shareholder Rights, Officers, Exhibits
8-K 2019-08-23 Other Events, Exhibits
8-K 2019-08-14 Other Events, Exhibits
8-K 2019-08-01 Other Events, Exhibits
8-K 2019-07-16 Other Events, Exhibits
8-K 2019-07-01 Enter Agreement, Shareholder Rights, Exhibits
8-K 2019-06-18 Officers
8-K 2019-05-29 Officers, Exhibits
8-K 2019-04-29 Leave Agreement, Officers
8-K 2019-04-29 M&A
8-K 2019-04-29 Officers, Other Events, Exhibits
8-K 2019-04-19 M&A
8-K 2019-04-14 Enter Agreement, Other Events, Exhibits
8-K 2019-04-12 Officers, Exhibits
8-K 2019-04-12 Other Events, Exhibits
8-K 2019-04-01 Enter Agreement
8-K 2019-03-31 Enter Agreement, Exhibits
8-K 2019-03-07 Enter Agreement, Exhibits
8-K 2019-02-21 Regulation FD
8-K 2019-01-08 Enter Agreement
8-K 2018-11-08 Earnings, Exhibits
8-K 2018-11-06 Enter Agreement, Shareholder Rights, Amend Bylaw, Other Events, Exhibits
8-K 2018-09-28 Earnings, Exhibits
8-K 2018-09-24 Amendment, Officers
8-K 2018-09-11 Enter Agreement, Exhibits
8-K 2018-07-10 Other Events, Exhibits
8-K 2018-06-01 Officers, Regulation FD, Exhibits
8-K 2018-05-03 Earnings, Exhibits
8-K 2018-04-16 Other Events
8-K 2018-04-12 Earnings, Officers, Regulation FD, Exhibits
8-K 2018-02-22 Other Events, Exhibits
8-K 2018-02-12 Officers, Exhibits

Aceto Financials

-

ACET Metrics, Comps, Filings


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Stockholders' Equity

Income Statement ($BB Quarter)

Revenue, Gross Profit, Net Income

Cash Flow ($BB Quarter)

Operating, Investing, Financing

Comps ($MM TTM) Market Cap Assets Liabilities Revenue Gross Profit Net Income EBITDA EV
McKesson (MCK) 24,784 61,680 53,806 217,440 11,762 812 1,925 30,529
Amerisourcebergen (ABC) 18,082 38,479 35,489 177,248 4,986 957 1,485 19,267
Cardinal Health (CAH) 13,735 40,963 34,635 145,534 6,835 1,365 3,046 18,783
Herbalife Nutrition (HLF) 6,147 3,079 3,613 4,842 3,913 293 587 7,498
NU Skin Enterprises (NUS) 2,709 1,791 956 2,606 1,986 125 306 2,757
Petiq (PETQ) 698 524 186 629 101 9 19 761
Fortress Biotech (FBIO) 85 227 137 88 5 -53 -49 10
Veru (VERU) 137 54 19 23 21 -11 -2 129
Otonomy (OTIC) 79 101 42 1 -0 -49 -49 15
Galmed Pharmaceuticals (GLMD) 153 91 3 0 0 0 0 128
Aveo Pharmaceuticals (AVEO) 113 42 40 6 0 -3 -1 96
Ophthotech (OPHT) 62 114 12 0 0 62 58 -45
Aceto (ACET) 29 753 703 683 87 -275 -207 305
Entasis Therapeutics Holdings (ETTX) 83 66 9 0 0 -43 -43 24
Psychemedics (PMD) 53 25 7 11 19 4 10 47
Nymox Pharmaceutical (NYMX) 92 8 1 0 0 0 0 92
Paratek Pharmaceuticals (PRTK) 125 277 290 21 3 -124 -109 55
Chimerix (CMRX) 181 163 14 5 0 -66 -66 160
MEI Pharma (MEIP) 187 83 35 5 1 -17 -17 112

Balance Sheet ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash28272524253533354234434137343431545367736860567265621015242
Accounts Receivable778475777896909388101123126148150162168152177168159224261265241242260247292262
Inventory798385869787848795100101929397969010610098104145140136135148142137157184
PP&E1212181212121911111121111111201010102110101022121314271413
Assets3013102993003153333233333403504684614804824904915245455415451,0451,0591,0411,0181,015831767775753
Accounts Payable3947423844503942404849444956554957614649901119098107125107123132
Long-Term Debt
Liabilities139141131126136148129125122126234226241241236225239246236235648656633609618628672701703
Stockholders' Equity162169168174179185195208218223234235239240254265286299304310396402408409397203957450
Income Statement ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Revenue111121111112114151123129117125140131124146147134132158135128126190195185171186169164164
Cost of Revenue90999090931199996871001111039410910599961201019795148158145137158159139140
Gross Profit2122212221322534292529283037413536383431314237403428102524
R&D1122102313221133222222
SG&A1415151414201616151618181919171819192021282727312828353737
Tax32133436633345865532-031213-667521
Net Income554558511105657814981074-1620-14-197-35-21-22
Cash Flow ($MM)2011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-31
Cash Operating53-315688-3-46-8
Cash Investing-120-10-0-0-01-1
Cash Financing-6-72-4-9-6-1-4-4-0